Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial — Jesús F. San Miguel (2013) | RDL Network
Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial
Meletios A Dimopoulos, Katja Weisel, Kevin Song, Michel Delforge, Lionel Karlin, Hartmut Goldschmidt, Philippe Moreau, A. Baños, Albert Oriol, Laurent Garderet, Michèle Cavo, Иванова, Adrían Alegre, Joaquín Martínez‐López, C. I Chen, A. Spencer, Stefan Knop, NJ Bahlis, C. Renner, Xiaoyan Yu, Kelvin Hong, Lars Sternås, Christian Jacques, Mohamed H. Zaki, Jesús F. San Miguel
Gillian Morgan, Jesús F. San Miguel, Sujith Dhanasiri, Dennis D. Lee, Antonio Palumbo, Thierry Façon, Mohamed H. Zaki, Xiaoyan Yu, Lars Sternås, Christian Jacques, Katja Weisel, Fritz Offner, Meletios A Dimopoulos
Hartmut Goldschmidt, Meletios A Dimopoulos, Katja Weisel, Philippe Moreau, Martha Q. Lacy, Kevin Song, Michel Delforge, Lionel Karlin, Anne Banos, Albert Oriol Rocafiguera, Xin Yu, Lars Sternås, Christian Jacques, Mohamed H. Zaki, Jesús F. San Miguel
Meletios A Dimopoulos, Evangelos Terpos, Mario Boccadoro, Sosana Delimpasi, Meral Beksaç, Eirini Katodritou, Philippe Moreau, Luca Baldini, Argiris Symeonidis, Jelena Bila, Albert Oriol, María‐Victoria Mateos, Hermann Einsele, Ioannis Orfanidis, Tahamtan Ahmadi, Jon Ukropec, Tobias Kampfenkel, Jordan M. Schecter, Yanping Qiu, Himal Amin, Jessica Vermeulen,
Kevin Song, Meletios A Dimopoulos, Katja Weisel, Philippe Moreau, Antonio Palumbo, Andrew Belch, Stephen Schey, Pieter Sonneveld, Lars Sternås, Xiaoyan Yu, Ramesh Amatya, Mara Silvia Monzini, Mohamed H. Zaki, Christian Jacques, Jesús F. San Miguel
Discussion(0)
No comments yet. Be the first to comment.